Clinicopathological and prognostic value of S100A4 expression in gastric cancer: A meta-analysis

International Journal of Biological Markers

Volumn 29, Issue 2, 2014, Pages

  Ling, Zhian ^a   Li, Ruolin ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; Meta analysis; Prognosis; S100A4

Indexed keywords

CALVASCULIN; PROTEIN S 100; S100A4 PROTEIN, HUMAN; TUMOR MARKER;

CALVASCULIN GENE; CANCER GRADING; CANCER PROGNOSIS; CANCER RECURRENCE; DATA EXTRACTION; DISEASE FREE SURVIVAL; GASTRECTOMY; GENE; GENE OVEREXPRESSION; HUMAN; META ANALYSIS; METASTASIS; OVERALL SURVIVAL; REVIEW; SENSITIVITY ANALYSIS; STOMACH CANCER; TUMOR INVASION; TUMOR VOLUME; BIOSYNTHESIS; DISEASE COURSE; FEMALE; MALE; METABOLISM; PATHOLOGY; PROGNOSIS; STOMACH TUMOR;

DISEASE PROGRESSION; FEMALE; HUMANS; MALE; PROGNOSIS; S100 PROTEINS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84903377185     PISSN: 03936155     EISSN: 17246008     Source Type: Journal    
DOI: 10.5301/jbm.5000054     Document Type: Review

References (37)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11-30.
2. Brenner H, Rothenbacher D, Arndt V. Epidemiology of stomach cancer. Methods Mol Biol. 2009;472:467-477.
3. Peeters KC, van de Velde CJ. Improving treatment outcome for gastric cancer: the role of surgery and adjuvant therapy. J Clin Oncol. 2003;21(23)(Suppl):272s-273s.
4. Hohenberger P, Gretschel S. Gastric cancer. Lancet. 2003; 362(9380):305-315.
5. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin. 2006;56(1):11-25, quiz 49-50.
6. Garrett SC, Varney KM, Weber DJ, Bresnick AR. S100A4, a mediator of metastasis. J Biol Chem. 2006;281(2):677-680.
7. Mishra SK, Siddique HR, Saleem M. S100A4 calcium-binding protein is key player in tumor progression and metastasis: preclinical and clinical evidence. Cancer Metastasis Rev. 2012;31(1-2):163-172.
8. de Silva Rudland S, Martin L, Roshanlall C, et al. Association of S100A4 and osteopontin with specific prognostic factors and survival of patients with minimally invasive breast cancer. Clin Cancer Res. 2006;12(4):1192-1200.
9. Sagara Y, Miyata Y, Iwata T, et al. Clinical significance and prognostic value of S100A4 and matrix metalloproteinase-14 in patients with organ-confined bladder cancer. Exp Ther Med. 2010;1(1):27-31.
10. Ninomiya I, Ohta T, Fushida S, et al. Increased expression of S100A4 and its prognostic significance in esophageal squamous cell carcinoma. Int J Oncol. 2001;18(4):715-720.
11. Tsuna M, Kageyama SI, Fukuoka J, et al. Significance of S100A4 as a prognostic marker of lung squamous cell carcinoma. Anticancer Res. 2009;29(7):2547-2554.
12. Lee SJ, Choi SY, Kim WJ, et al. Combined aberrant expression of E-cadherin and S100A4, but not o-catenin is associated with disease-free survival and overall survival in colorectal cancer patients. Diagn Pathol. 2013;8(1):99.
13. Stein U, Burock S, Herrmann P, et al. Diagnostic and prognostic value of metastasis inducer S100A4 transcripts in plasma of colon, rectal, and gastric cancer patients. J Mol Diagn. 2011;13(2):189-198.
14. Yoon CS, Hyung WJ, Lee JH, et al. Expression of S100A4, Ecadherin, alpha-and beta-catenin in gastric adenocarcinoma. Hepatogastroenterology. 2008;55(86-87):1916-1920.
15. Yonemura Y, Endou Y, Kimura K, et al. Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer. Clin Cancer Res. 2000;6(11): 4234-4242.
16. Cho YG, Nam SW, Kim TY, et al. Overexpression of S100A4 is closely related to the aggressiveness of gastric cancer. APMIS. 2003;111(5):539-545.
17. Yu GZ, Wang JJ, Chen Y, Ni CR, Zhu MH. [Expressions of nm23, P53 and S100A4 proteins and their relationships with metastasis potential in gastric carcinoma]. Zhonghua Wei Chang Wai Ke Za Zhi. 2006;9(2):165-169.
18. Zhong XY, Zhang LH, Jia SQ, et al. [Nuclear expression of S100A4 is associated with lymph node metastasis in gastric carcinoma]. Zhonghua Wei Chang Wai Ke Za Zhi. 2007;10(5):454-457.
19. Kim YJ, Kim MA, Im SA, et al. Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer. Cancer Invest. 2008;26(2):152-158.
20. Kim MA, Lee HS, Lee HE, Kim JH, Yang HK, Kim WH. Prognostic importance of epithelial-mesenchymal transitionrelated protein expression in gastric carcinoma. Histopathology. 2009;54(4):442-451.
21. Wang YY, Ye ZY, Zhao ZS, Tao HQ, Chu YQ. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer. Ann Surg Oncol. 2010;17(1):89-97.
22. Feng LZ, Zheng XY, Zhou LX, et al. Correlation between expression of S100A4 and VEGF-C, and lymph node metastasis and prognosis in gastric carcinoma. J Int Med Res. 2011;39(4):1333-1343.
23. Li H, Liu Z, Xu C, et al. Overexpression of S100A4 is closely associated with the progression and prognosis of gastric cancer in young patients. Oncol Lett. 2013;5(5):1485-1490.
24. Zhao Y, Zhang T, Wang Q. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas. Oncol Rep. 2013;30(1): 111-118.
25. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17(24):2815-2834.
26. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558.
27. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414): 557-560.
28. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188.
29. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719-748.
30. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088-1101.
31. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-634.
32. Duval S, Tweedie R. Trim and fill: A simple funnel-plotbased method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455-463.
33. Shen W, Chen D, Fu H, Liu S, Sun K, Sun X. S100A4 protects gastric cancer cells from anoikis through regulation of αv and α5 integrin. Cancer Sci. 2011;102(5):1014-1018.
34. Liu J, Li X, Dong GL, et al. In silico analysis and verification of S100 gene expression in gastric cancer. BMC Cancer. 2008;8(1):261.
35. Li Y, Zhang KL, Sun Y, et al. Frequent s100a4 expression with unique splicing pattern in gastric cancers: A hypomethylation event paralleled with e-cadherin reduction and wnt activation. Transl Oncol. 2008;1(4):165-176.
36. Li JH, Zhang SW, Liu J, Shao MZ, Chen L. Review of clinical investigation on recurrence of gastric cancer following curative resection. Chin Med J (Engl). 2012;125(8): 1479-1495.
37. Lloyd BH, Platt-Higgins A, Rudland PS, Barraclough R. Human S100A4 (p9Ka) induces the metastatic phenotype upon benign tumour cells. Oncogene. 1998;17(4):465-473.